Fujita M - Search Results

1

Light/dark phase-dependent spontaneous activity is maintained in dopamine-deficient mice.

Fujita M, Hagino Y, Takeda T, Kasai S, Tanaka M, Takamatsu Y, Kobayashi K, Ikeda K. Fujita M, et al. Mol Brain. 2017 Oct 16;10(1):49. doi: 10.1186/s13041-017-0329-4. Mol Brain. 2017. PMID: 29037208 Free PMC article.

2

Involvement of cholinergic system in hyperactivity in dopamine-deficient mice.

Hagino Y, Kasai S, Fujita M, Setogawa S, Yamaura H, Yanagihara D, Hashimoto M, Kobayashi K, Meltzer HY, Ikeda K. Hagino Y, et al. Among authors: fujita m. Neuropsychopharmacology. 2015 Mar 13;40(5):1141-50. doi: 10.1038/npp.2014.295. Neuropsychopharmacology. 2015. PMID: 25367503 Free PMC article.

3

Opioid and nondopamine reward circuitry and state-dependent mechanisms.

Fujita M, Ide S, Ikeda K. Fujita M, et al. Ann N Y Acad Sci. 2019 Sep;1451(1):29-41. doi: 10.1111/nyas.13605. Epub 2018 Mar 7. Ann N Y Acad Sci. 2019. PMID: 29512887 Review.

4

Immature-like molecular expression patterns in the hippocampus of a mouse model of dementia with Lewy body-linked mutant β-synuclein.

Hagihara H, Fujita M, Umemori J, Hashimoto M, Miyakawa T. Hagihara H, et al. Among authors: fujita m. Mol Brain. 2018 Jul 6;11(1):38. doi: 10.1186/s13041-018-0378-3. Mol Brain. 2018. PMID: 29976232 Free PMC article.

5

Early manifestation of depressive-like behavior in transgenic mice that express dementia with Lewy body-linked mutant β-synuclein.

Fujita M, Hagino Y, Takamatsu Y, Shimizu Y, Takamatsu Y, Ikeda K, Hashimoto M. Fujita M, et al. Neuropsychopharmacol Rep. 2018 Jun;38(2):95-97. doi: 10.1002/npr2.12009. Epub 2018 Mar 7. Neuropsychopharmacol Rep. 2018. PMID: 30106256 Free PMC article.

6

Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein.

Fujita M, Ho G, Takamatsu Y, Wada R, Ikeda K, Hashimoto M. Fujita M, et al. Int J Mol Sci. 2020 Apr 19;21(8):2849. doi: 10.3390/ijms21082849. Int J Mol Sci. 2020. PMID: 32325870 Free PMC article. Review.

7

Increase in excitability of hippocampal neurons during novelty-induced hyperlocomotion in dopamine-deficient mice.

Fujita M, Ochiai Y, Takeda TC, Hagino Y, Kobayashi K, Ikeda K. Fujita M, et al. Mol Brain. 2020 Sep 18;13(1):126. doi: 10.1186/s13041-020-00664-8. Mol Brain. 2020. PMID: 32948232 Free PMC article.

8

Correction to: Increase in excitability of hippocampal neurons during novelty-induced hyperlocomotion in dopamine-deficient mice.

Fujita M, Ochiai Y, Takeda TC, Hagino Y, Kobayashi K, Ikeda K. Fujita M, et al. Mol Brain. 2021 Mar 11;14(1):51. doi: 10.1186/s13041-021-00741-6. Mol Brain. 2021. PMID: 33706796 Free PMC article. No abstract available.

9

Impaired wakefulness and rapid eye movement sleep in dopamine-deficient mice.

Kashiwagi M, Kanuka M, Tanaka K, Fujita M, Nakai A, Tatsuzawa C, Kobayashi K, Ikeda K, Hayashi Y. Kashiwagi M, et al. Among authors: fujita m. Mol Brain. 2021 Nov 18;14(1):170. doi: 10.1186/s13041-021-00879-3. Mol Brain. 2021. PMID: 34794460 Free PMC article.

10

Therapeutic Effects of Quetiapine and 5-HT_1A Receptor Agonism on Hyperactivity in Dopamine-Deficient Mice.

Ochiai Y, Fujita M, Hagino Y, Kobayashi K, Okiyama R, Takahashi K, Ikeda K. Ochiai Y, et al. Among authors: fujita m. Int J Mol Sci. 2022 Jul 4;23(13):7436. doi: 10.3390/ijms23137436. Int J Mol Sci. 2022. PMID: 35806448 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,394 results

Search Page

Filters